LIGAND PHARMACEUTICALS INCORPORATED Increase (Decrease) in Income Taxes Receivable
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Increase (Decrease) in Income Taxes Receivable of -$522.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for the quarter ending 2026-06-30 was $173.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for the quarter ending 2026-03-31 was -$695.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for the quarter ending 2025-12-31 was $955.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for the quarter ending 2025-09-30 was -$864.00K, a 109.50% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for fiscal 2025 was -$2.67M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for fiscal 2024 was -$2.31M, a 229.70% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for fiscal 2023 was $1.78M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes receivable for fiscal 2022 was -$1.58M, a 139.71% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$522.00K 10-Q · filed 2026-08-07 | $433.00K derived: sum of 3 quarters · filed 2026-08-07 | -$431.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$695.00K 10-Q · filed 2026-05-08 | $260.00K derived: sum of 2 quarters · filed 2026-05-08 | -$604.00K derived: sum of 3 quarters · filed 2026-05-08 | -$3.03M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $91.00K derived: sum of 2 quarters · filed 2026-02-27 | -$2.33M derived: sum of 3 quarters · filed 2026-08-07 | -$2.67M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$864.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$3.29M derived: sum of 2 quarters · filed 2026-08-07 | -$3.62M 10-Q · filed 2025-11-07 | -$6.54M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$2.76M 10-Q · filed 2026-08-07 | -$5.67M derived: sum of 3 quarters · filed 2026-08-07 | $3.42M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$335.00K 10-Q · filed 2026-05-08 | -$3.25M derived: sum of 2 quarters · filed 2026-05-08 | $5.84M derived: sum of 3 quarters · filed 2026-05-08 | $4.89M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.18M derived: sum of 2 quarters · filed 2026-02-27 | $5.22M derived: sum of 3 quarters · filed 2026-02-27 | -$2.31M 10-K · filed 2026-02-27 |
| 2024-09-30 | $9.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $8.14M derived: sum of 2 quarters · filed 2025-11-07 | $607.00K 10-Q · filed 2025-11-07 | $8.21M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$953.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$8.49M 10-Q · filed 2025-08-08 | -$887.00K derived: sum of 3 quarters · filed 2026-02-27 | $9.30M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$7.53M 10-Q · filed 2025-05-09 | $66.00K derived: sum of 2 quarters · filed 2026-02-27 | $10.25M derived: sum of 3 quarters · filed 2026-02-27 | -$1.14M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.78M derived: sum of 2 quarters · filed 2026-02-27 | $6.39M derived: sum of 3 quarters · filed 2026-02-27 | $1.78M 10-K · filed 2026-02-27 |
| 2023-09-30 | $10.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.20M derived: sum of 2 quarters · filed 2024-11-08 | -$5.82M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | -$11.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$16.00M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$4.61M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$1.58M 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $3.98M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | -$9.14M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $11.22M 10-K · filed 2022-02-28 | |||
| 2018-12-31 | -$318.00K 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $460.00K 10-K · filed 2020-02-27 |